Company signals · MedTech
Abbott
5 signals in the current window, with MitchelLake's leadership read on each.
Last updated
Market context: Against a Talent Market Index of 105.8 (Hot) (down 2.4 month-on-month), Americas is at rising (+2.4pts) on signal share.
Abbott: 2 signals in the last 90 days — above the MedTech median of 1 across 20 tracked companies; 0.2% of MitchelLake's Americas signal flow; 5 tracked across 83 days.
Signals at Abbott
Product Launch
EMEAAbbott launched CE-marked dual glucose-ketone Libre Duo sensors in Europe through expanded partnership with MiniMed, representing first-of-its-kind dual-analyte diabetes technology
Leadership read: Product momentum tends to widen medtech product and commercial leadership bench strength.
curated · 2026-06-14 · context →
Product Launch
AmericasAbbott is presenting at DeviceTalks Minnesota 2026 conference (May 4) with senior executive speaker Lisa Earnhardt, indicating active participation in medical device sector events and likely product/innovation showcase.
Leadership read: Product momentum tends to widen medtech product and commercial leadership bench strength.
curated · 2026-05-01 · context →
Product Launch
AmericasAbbott presenting new data on Cancerguard Multi-Cancer Early Detection Test at AACR 2026, showing advancements in multi-biomarker approach for early-stage cancer detection
Leadership read: Product momentum tends to widen medtech product and commercial leadership bench strength.
curated · 2026-04-17 · context →
Ma Activity
AmericasAbbott completed acquisition of Exact Sciences, establishing itself as a leader in the fast-growing oncology diagnostics market
Leadership read: Consolidation of this kind shifts demand toward integration and transformation leadership bench strength in medtech.
curated · 2026-04-16 · context →
Ma Activity
AmericasAbbott completes acquisition of Exact Sciences, establishing Abbott as a leader in cancer screening and diagnostics segments
Leadership read: Consolidation of this kind shifts demand toward integration and transformation leadership bench strength in medtech.
curated · 2026-03-23 · context →
- Product Launch · 2026-06-14
- Product Launch · 2026-05-01
- Product Launch · 2026-04-17
- Ma Activity · 2026-04-16
- Ma Activity · 2026-03-23
MitchelLake in this thematic
More signals across MedTech
Ma Activity · Americas
Medtronic →Medtronic completed acquisition of SPR Therapeutics for $650M cash. SPR specializes in FDA-cleared short-term peripheral nerve stimulation (PNS) therapy for chronic and acute pain. Deal adds SPRINT PNS System to Medtronic's neuromodulation portfolio.
Ma Activity · Americas
Analog Devices →Analog Devices completed acquisition of Empower Semiconductor to strengthen its position as a power partner across the AI ecosystem
Ma Activity · Americas
Boston Scientific →Boston Scientific invested $1.5bn to acquire a 34% equity stake in MiRus, an implants and procedural solutions developer
Ma Activity · Americas
McKesson →McKesson planning medical-surgical spinoff and share buyback program, indicating major portfolio restructuring
Ma Activity · Americas
QuidelOrtho Corporation →QuidelOrtho Corporation completed acquisition of LEX Diagnostics, expanding into point-of-care molecular diagnostics with ultra-fast PCR platform delivering results in ~10 minutes
Intelligence powered by Autonodal ↗